xCELLigence RTCA- impedance biosensors to continuously monitor changes in cell number, cell morphology, cell-substrate attachment strength, and cell barrier function.Track the same population of cells via three-color live cell imaging.

In this webinar, Dr.Roddy O'Connor will discuss how T cells can be genetically modified with synthetic receptors "CARs" that redirect their specificity against distinct tumor antigens.

Leukemia is a cancer of the body's blood-forming tissues, including bone marrow (Acute myeloid leukemia-AML) and the lymphatic system (Acute lymphatic leukemia-ALL).From a metabolic perspective, acquired chemoresistance is associated with a shift...

Dr.Yuting Sun discusses her research supporting a Phase 1 clinical trial advancing cancer therapies, targeted at metabolic vulnerabilities.Strategies in targeting two metabolic vulnerabilities-FHmut cancer and glycolysis-deficient cancer.

The rate of cellular ATP production is a powerful and straightforward measurement of energy metabolism.This webinar will discuss how OCR and ECAR can be easily converted into rates of mitochondrial and glycolytic ATP production.This routine method...

Dr.John Connolly, Tessa Therapeutics, will present a novel flow cytometry-based method to demonstrate the importance of metabolic change in memory T cell differentiation, highlight these factors as attributes of adoptive T cell therapy.

In this webinar, Dr.Olaf Groß will discuss a link between metabolism and NLRP3 which has long been postulated and is supported by in vivo evidence and inhibitor data.

This webinar will discuss the concept of metabolic plasticity.

In this webinar, Dr.Jeffrey Rathmell will discuss mechanisms of metabolic reprogramming in T cell activation and differentiation.The tumor microenvironment and inflammatory cues influence T cell nutrient uptake and metabolism, and these pathways...

This webinar will discuss the early and late metabolic changes that occur during T cell activation.

This webinar will discuss how Brown Adipocytes (BAT) provide a unique therapeutic strategy to target metabolic disorders such as obesity and type 2 diabetes.

必威体育登录手机In this webinar, Eva Szabo MSc, PhD will discuss how to use the Agilent Seahorse XF Analyzer to study human neural differentiation and neurodegenerative diseases.

This webinar assesses the Seahorse XF platform as a tool for screening mitochondrial dysfunction and presents a workflow with reference to a panel of mitochondrial toxic drugs.

Introducing the XF Substrate Oxidation Stress Tests, a robust portfolio of XF assays enabling insights into cellular substrate dependencies to identify specific mitochondrial substrates that are relevant for cellular phenotype and function.

Using the Seahorse XF Technology, we investigated how Mtb reprogrammed the bioenergetic metabolism of the human host in vitro and ex vivo.

In this webinar, the basic principles of data normalization and how these ideas impact Seahorse XF data will be discussed.

In this webinar, Dr.Victor Darley-Usmar will introduce a new concept known as the bioenergetic-metabolite interactome, which describes how defining our bioenergetic health at the level of individual cells can now be achieved.Although we have known...

In this webinar, Dr.Sandra Milasta, Senior Scientist of Elevatebio will discuss how metabolic pathways maintain lymphocyte survival, drive memory vs.effector function, and the implications of these findings on the development of next generation T...

In this webinar, Dr.Stephen Black will discuss the link between the disruption of ß-oxidation and mitochondrial function in the development of pulmonary endothelial dysfunction.Pulmonary vascular disease is a serious complication for children born...

This webinar will discuss how we can selectively demolish intramural Tregs by targeting unique metabolic preference of intratumoral Tregs and how this approach can be utilized for cancer research.